Evidence map›Paper›PMID 15919894›Full record

ArticleJournal of virology2005

The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding.

Marketa Vlasak, Merja Roivainen, Manuela Reithmayer, Irene Goesler, Pia Laine, Luc Snyers, Tapani Hovi, Dieter Blaas

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Rhinovirus Attributes that Contribute to Asthma Development.Immunology and allergy clinics of North America · 2019
    Review
  9. Review
  10. Article
  11. Article
  12. Immune Responses in Rhinovirus-Induced Asthma Exacerbations.Current allergy and asthma reports · 2016
    Review
  13. Article
  14. Viral entry pathways: the example of common cold viruses.Wiener medizinische Wochenschrift (1946) · 2016
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Classification and evolution of human rhinoviruses.Methods in molecular biology (Clifton, N.J.) · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Marketa VlasakMax F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Medical Biochemistry, Medical University of Vienna, Dr. Bohr Gasse 9/3, A-1030 Vienna, Austria.
Merja Roivainen
Manuela Reithmayer
Irene Goesler
Pia Laine
Luc Snyers
Tapani Hovi
Dieter Blaas
Institute for Molecular Medicine Finland · FIMax Perutz Labs · ATVienna Biocenter · ATMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Like all 10 minor receptor group human rhinoviruses (HRVs), HRV23 and HRV25, previously classified as major group viruses, are neutralized by maltose binding protein (MBP)-V33333 (a soluble recombinant concatemer of five copies of repeat 3 of the very-low-density lipoprotein receptor fused to MBP), bind to low-density lipoprotein receptor in virus overlay blots, and replicate in intercellular adhesion molecule 1 (ICAM-1)-negative COS-7 cells. From phylogenetic analysis of capsid protein VP1-coding sequences, they are also known to cluster together with other minor group strains. Therefore, they belong to the minor group; there are now 12 minor group and 87 major group HRV serotypes. Sequence comparison of the VP1 capsid proteins of all HRVs revealed that the lysine in the HI loop, strictly conserved in the 12 minor group HRVs, is also present in 9 major group serotypes that are neutralized by soluble ICAM-1. Despite the presence of this lysine, they are not neutralized by MBP-V33333 and fail to replicate in COS-7 cells and in HeLa cells in the presence of an ICAM-1-blocking antibody. These nine serotypes are therefore "true" major group viruses.

Indexed as

LysineAmino Acid SequenceAnimalsBinding SitesCarrier ProteinsChlorocebus aethiopsCOS CellsHeLa CellsHumansMaltose-Binding ProteinsMolecular Sequence DataReceptors, Cytoplasmic and NuclearReceptors, LDLRhinovirusSequence AlignmentSerotypingCarrier ProteinsLysineMaltose-Binding ProteinsReceptors, Cytoplasmic and NuclearReceptors, LDLTranscription Factorsviral protein 1, rhinovirusViral Proteins

Identifiers

PMID15919894
PMCPMC1143622
OpenAlexW2095394002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.